266 related articles for article (PubMed ID: 17470546)
1. Marginal zone B-cell depletion impairs murine host defense against Borrelia burgdorferi infection.
Belperron AA; Dailey CM; Booth CJ; Bockenstedt LK
Infect Immun; 2007 Jul; 75(7):3354-60. PubMed ID: 17470546
[TBL] [Abstract][Full Text] [Related]
2. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d.
Belperron AA; Dailey CM; Bockenstedt LK
J Immunol; 2005 May; 174(9):5681-6. PubMed ID: 15843569
[TBL] [Abstract][Full Text] [Related]
3. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice.
Liu N; Montgomery RR; Barthold SW; Bockenstedt LK
Infect Immun; 2004 Jun; 72(6):3195-203. PubMed ID: 15155621
[TBL] [Abstract][Full Text] [Related]
4. IgE anti-Borrelia burgdorferi components (p18, p31, p34, p41, p45, p60) and increased blood CD8+CD60+ T cells in children with Lyme disease.
Bluth MH; Robin J; Ruditsky M; Norowitz KB; Chice S; Pytlak E; Nowakowski M; Durkin HG; Smith-Norowitz TA
Scand J Immunol; 2007 Apr; 65(4):376-82. PubMed ID: 17386029
[TBL] [Abstract][Full Text] [Related]
5. Effect of anti-interleukin 12 treatment on murine lyme borreliosis.
Anguita J; Persing DH; Rincon M; Barthold SW; Fikrig E
J Clin Invest; 1996 Feb; 97(4):1028-34. PubMed ID: 8613525
[TBL] [Abstract][Full Text] [Related]
6. Fas ligand deficiency impairs host inflammatory response against infection with the spirochete Borrelia burgdorferi.
Shi C; Wolfe J; Russell JQ; Fortner K; Hardin N; Anguita J; Budd RC
Infect Immun; 2006 Feb; 74(2):1156-60. PubMed ID: 16428764
[TBL] [Abstract][Full Text] [Related]
7. T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice.
Keane-Myers A; Nickell SP
J Immunol; 1995 Feb; 154(4):1770-6. PubMed ID: 7836761
[TBL] [Abstract][Full Text] [Related]
8. Age-Related Differential Stimulation of Immune Response by
Djokic V; Primus S; Akoolo L; Chakraborti M; Parveen N
Front Immunol; 2018; 9():2891. PubMed ID: 30619263
[TBL] [Abstract][Full Text] [Related]
9. Arthritogenicity of Borrelia burgdorferi and Borrelia garinii: comparison of infection in mice.
Craig-Mylius KA; Lee M; Jones KL; Glickstein LJ
Am J Trop Med Hyg; 2009 Feb; 80(2):252-8. PubMed ID: 19190223
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cells promote antibody production but not sustained affinity maturation during Borrelia burgdorferi infection.
Elsner RA; Hastey CJ; Baumgarth N
Infect Immun; 2015 Jan; 83(1):48-56. PubMed ID: 25312948
[TBL] [Abstract][Full Text] [Related]
11. The loss and gain of marginal zone and peritoneal B cells is different in response to relapsing fever and Lyme disease Borrelia.
Malkiel S; Kuhlow CJ; Mena P; Benach JL
J Immunol; 2009 Jan; 182(1):498-506. PubMed ID: 19109181
[TBL] [Abstract][Full Text] [Related]
12. Delays and diversions mark the development of B cell responses to Borrelia burgdorferi infection.
Hastey CJ; Elsner RA; Barthold SW; Baumgarth N
J Immunol; 2012 Jun; 188(11):5612-22. PubMed ID: 22547698
[TBL] [Abstract][Full Text] [Related]
13. Borrelia burgdorferi, an extracellular pathogen, circumvents osteopontin in inducing an inflammatory cytokine response.
Craig-Mylius K; Weber GF; Coburn J; Glickstein L
J Leukoc Biol; 2005 May; 77(5):710-8. PubMed ID: 15695554
[TBL] [Abstract][Full Text] [Related]
14. Role of marginal zone B lymphocytes in invariant NKT cell activation.
Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
[TBL] [Abstract][Full Text] [Related]
15. Impaired host defense to infection and Toll-like receptor 2-independent killing of Borrelia burgdorferi clinical isolates in TLR2-deficient C3H/HeJ mice.
Wang G; Ma Y; Buyuk A; McClain S; Weis JJ; Schwartz I
FEMS Microbiol Lett; 2004 Feb; 231(2):219-25. PubMed ID: 14987768
[TBL] [Abstract][Full Text] [Related]
16. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
Zhong W; Gern L; Kramer M; Wallich R; Simon MM
Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
[TBL] [Abstract][Full Text] [Related]
17. Dual role for Fcγ receptors in host defense and disease in Borrelia burgdorferi-infected mice.
Belperron AA; Liu N; Booth CJ; Bockenstedt LK
Front Cell Infect Microbiol; 2014; 4():75. PubMed ID: 24967215
[TBL] [Abstract][Full Text] [Related]
18. Analysis of some peripheral blood lymphocyte subsets in relation to Borrelia burgdorferi antibodies in patients with Lyme disease.
Zajkowska JM; Hermanowska-Szpakowicz T; Wysocka J; Kondrusik M; Pancewicz SA; Grygorczuk S
Rocz Akad Med Bialymst; 2000; 45():184-98. PubMed ID: 11712430
[TBL] [Abstract][Full Text] [Related]
19. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.
Nardelli DT; Burchill MA; England DM; Torrealba J; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1075-84. PubMed ID: 15539509
[TBL] [Abstract][Full Text] [Related]
20. Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice.
Keane-Myers A; Maliszewski CR; Finkelman FD; Nickell SP
J Immunol; 1996 Apr; 156(7):2488-94. PubMed ID: 8786309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
